Septic Shock
51 drugs17,587 FAERS reportsMedDRA PT
GET
/api/v1/reaction/septic-shockReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D012772
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
Source: U.S. National Library of Medicine — MeSH (Shock, Septic)
Drugs reporting Septic Shock (51)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Omidubicel422%
- 2Gluconolactone212%
- 3Azurite111%
- 4Cornsilk111%
- 5Emapalumab1910%
- 6Anidulafungin1288.2%
- 7Ethanolamine15.6%
- 8Ethanolamine Oleate15.6%
- 9Oleate15.6%
- 10Norepinephrine6534.7%
- 11Meropenem1,3864.4%
- 12Ceftazidime3384.4%
- 13Caspofungin1854.0%
- 14Tigecycline2293.8%
- 15Cefiderocol113.6%
- 16Daunorubicin1193.3%
- 17Clofarabine733.2%
- 18Cefepime4983.2%
- 19Nelarabine303.2%
- 20Cytarabine1,9183.2%
- 21Cilastatin1293.1%
- 22Imipenem1293.1%
- 23Mitoxantrone1933.1%
- 24Piperacillin9763.0%
- 25Tazobactam9943.0%
- 26Defibrotide1032.9%
- 27Micafungin2372.9%
- 28Posaconazole4502.9%
- 29Pegaspargase3352.8%
- 30Vancomycin1,7892.8%
- 31Amphotericin5392.7%
- 32Amphotericin B5392.7%
- 33Avibactam42.5%
- 34Ganciclovir2702.5%
- 35Ceftolozane242.5%
- 36Cefotaxime1032.4%
- 37Idarubicin262.4%
- 38Gentamicin3672.4%
- 39Glasdegib112.4%
- 40Idarucizumab332.3%
- 41Vincristine6592.3%
- 42Voriconazole6802.3%
- 43Linezolid6222.2%
- 44Etoposide1,5662.1%
- 45Cisatracurium462.1%
- 46Carmustine972.1%
- 47Calaspargase Pegol142.1%
- 48Remdesivir2732.1%
- 49Ceftriaxone7011.9%
- 50Fidaxomicin431.8%
- 51Glofitamab371.8%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Multiple Organ Dysfunction Syndrome22 shared · 0.27
- Respiratory Failure30 shared · 0.26
- Pancytopenia24 shared · 0.20
- Sepsis42 shared · 0.19
- Febrile Neutropenia28 shared · 0.15
- Thrombocytopenia36 shared · 0.15
- Drug Reaction With Eosinophilia And Systemic Symptoms10 shared · 0.14
- Neutropenia28 shared · 0.11
- Drug Resistance11 shared · 0.10
- Shock6 shared · 0.10
Literature
Recent PubMed references pinned to Shock, Septic as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Fatal Panton-Valentine leukocidin-positive MSSA toxic shock syndrome: a call for rapid virulence detection and optimized antimicrobial therapy.Frontiers in cellular and infection microbiology · 2026 · Zhao C, Ren R, Wu W, et al.PMID 42205483DOI 10.3389/fcimb.2026.1805801
- Successful Multidisciplinary Management of Esophageal Perforation Complicated by Septic Shock: A Race Against Time.The American journal of case reports · 2026 · Sewify K, Alshamrani AS, Zakary N, et al.PMID 42201853DOI 10.12659/AJCR.952553
- Recombinant human brain natriuretic peptide for the recovery stage of septic shock: an interventional study protocol.BMJ open · 2026 · Luo JC, Mou T, Li M, et al.PMID 42192636DOI 10.1136/bmjopen-2025-110628
- Pantoprazole Use in Invasively Ventilated Patients With Septic Shock: A Protocol and Statistical Analysis Plan.Acta anaesthesiologica Scandinavica · 2026 · Kuriyama A, Heels-Ansdell D, Fernando SM, et al.PMID 42186360DOI 10.1111/aas.70267
- PPARγ Variant rs10865710 and Mortality in Pediatric Septic Shock Stratified by Corticosteroid Exposure.Critical care explorations · 2026 · Bonnefil V, Standage S, Lautz AJ, et al.PMID 42183751DOI 10.1097/CCE.0000000000001410
- Mycobacterium abscessus bacteremia complicated by sepsis and septic shock in a patient with multiple comorbidities: a case report.Frontiers in immunology · 2026 · Xu Y, Wang L, Li H, et al.PMID 42183259DOI 10.3389/fimmu.2026.1834557
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.